| 1. |
van Kampen SC, Wanner A, Edwards M, et al. International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review. BMJ Glob Health, 2018, 3: e000745.
|
| 2. |
孫永昌. 關注肺結核在 COPD 發生發展中的作用. 國際呼吸雜志, 2019, 39(16): 1201-1203.
|
| 3. |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health study): a national cross-sectional study. Lancet, 2018, 391(10131): 1706-1717.
|
| 4. |
全國結核病流行病學抽樣調查技術指導組, 全國結核病流行病學抽樣調查辦公室. 2010 年全國肺結核患病率現況調查. 中華結核和呼吸雜志, 2012, 35(9): 665-668.
|
| 5. |
Global tuberculosis report 2020. Geneva: World Health Organization; 2020.
|
| 6. |
Gao L, Li X, Liu J, et al. Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis, 2017, 17(10): 1053-1061.
|
| 7. |
Jin J, Yu W, Li S, et al. Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease. Medicine (Baltimore), 2016, 95(29): e4219.
|
| 8. |
Liang Y, Yangzom D, Tsokyi L, et al. Clinical and radiological features of COPD patients living at ≥3000 m above sea level in the Tibet plateau. Int J Chron Obstruct Pulmon Dis, 2021, 16: 2445-2454.
|
| 9. |
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2022 Report. Available from:http://www.goldcopd.org/, Accessed February 15, 2022.
|
| 10. |
Menezes AM, Hallal PC, Perez-Padilla R, et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J, 2007, 30(6): 1180-1185.
|
| 11. |
Lam KB, Jiang CQ, Jordan RE, et al. Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou Biobank Cohort Study. Chest, 2010, 137(3): 593-600.
|
| 12. |
Lee CH, Lee MC, Lin HH, et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS One, 2012, 7(5): e37978.
|
| 13. |
Smith M, Li L, Augustyn M, et al. Prevalence and correlates of airflow obstruction in ~317, 000 never-smokers in China. Eur Respir J, 2014, 44(1): 66-77.
|
| 14. |
Pasipanodya JG, Miller TL, Vecino M, et al. Pulmonary impairment after tuberculosis. Chest, 2007, 131(6): 1817-1824.
|
| 15. |
Ko Y, Lee YM, Lee HY, et al. Changes in lung function according to disease extent before and after pulmonary tuberculosis. Int J Tuberc Lung Dis, 2015, 19(5): 589-595.
|
| 16. |
Amaral AF, Coton S, Kato B, et al. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J, 2015, 46(4): 1104-1112.
|
| 17. |
Hwang YI, Kim JH, Lee CY, et al. The association between airflow obstruction and radiologic change by tuberculosis. J Thorac Dis, 2014, 6(5): 471-476.
|
| 18. |
Jung JW, Choi JC, Shin JW, et al. Pulmonary impairment in tuberculosis survivors: The Korean National Health and Nutrition Examination Survey 2008-2012. PLoS One, 2015, 10(10): e0141230.
|
| 19. |
Jin J, Li S, Yu W, et al. Emphysema and bronchiectasis in COPD patients with previous pulmonary tuberculosis: computed tomography features and clinical implications. Int J Chron Obstruct Pulmon Dis, 2018, 13: 375-384.
|
| 20. |
Yakar HI, Gunen H, Pehlivan E, et al. The role of tuberculosis in COPD. Int J Chron Obstruct Pulmon Dis, 2017, 12: 323-329.
|
| 21. |
Bromberg PA, Robin ED. Abnormalities of lung function in tuberculosis. Bibl Tuberc, 1963, 17: 1-27.
|
| 22. |
Snider GL, Doctor L, Demas TA, et al. Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis, 1971, 103(5): 625-640.
|
| 23. |
Martin CJ, Cochran TH, Katsura S. Tuberculosis, emphysema, and bronchitis. Am Rev Respir Dis, 1968, 97(6): 1089-1094.
|
| 24. |
Siddharthan T, Gupte A, Barnes PJ. Chronic obstructive pulmonary disease endotypes in low- and middle-income country settings: precision medicine for all. Am J Respir Crit Care Med, 2020, 202(2): 171-172.
|
| 25. |
Gupte AN, Paradkar M, Selvaraju S, et al. Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD. PLoS One, 2019, 14(12): e0217289.
|
| 26. |
Allwood BW, Maasdorp E, Kim GJ, et al. Transition from restrictive to obstructive lung function impairment during treatment and follow-up of active tuberculosis. Int J Chron Obstruct Pulmon Dis, 2020, 15: 1039-1047.
|
| 27. |
Meghji J, Simpson H, Squire SB, et al. A systematic review of the prevalence and pattern of imaging defined post-TB lung disease. PLoS One, 2016, 11(8): e0161176.
|
| 28. |
Meghji J, Lesosky M, Joekes E, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax, 2020, 75(3): 269-278.
|
1/5
WeChat